Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 5
2016 4
2017 4
2018 6
2019 4
2020 5
2021 9
2022 3
2023 3
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Thomas D, et al. Among authors: radhakrishna n. Allergy. 2024 Feb;79(2):384-392. doi: 10.1111/all.15867. Epub 2023 Aug 25. Allergy. 2024. PMID: 37632144
Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma.
Denton E, Hore-Lacy F, Radhakrishna N, Gilbert A, Tay T, Lee J, Dabscheck E, Harvey ES, Bulathsinhala L, Fingleton J, Price D, Gibson PG, O'Hehir R, Hew M. Denton E, et al. Among authors: radhakrishna n. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1440-1449. doi: 10.1016/j.jaip.2019.02.042. Epub 2019 Apr 4. J Allergy Clin Immunol Pract. 2019. PMID: 30954467 Review.
Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study.
Douglass JA, Lodge C, Chan S, Doherty A, Tan JA, Jin C, Stewart A, Southcott AM, Gillman A, Lee J, Csutoros D, Hannan L, Ruane L, Barnes S, Irving L, Harun NS, Lachapelle P, Spriggs K, Sutherland M, See K, McDonald CF, Conron M, Radhakrishna N, Worsnop C, Johnston FH, Davies JM, Bryant V, Iles L, Ranson D, Spanos P, Vicendese D, Lowe A, Newbigin EJ, Bardin P, Dharmage S. Douglass JA, et al. Among authors: radhakrishna n. J Allergy Clin Immunol. 2022 May;149(5):1607-1616. doi: 10.1016/j.jaci.2021.10.028. Epub 2021 Nov 11. J Allergy Clin Immunol. 2022. PMID: 34774618
Addressing ethnic disparity in asthma trials.
Radhakrishna N, Hew M. Radhakrishna N, et al. Respirology. 2014 Aug;19(6):775-6. doi: 10.1111/resp.12338. Epub 2014 Jun 26. Respirology. 2014. PMID: 24975919 No abstract available.
Gastric Adenocarcinoma in a 16-Year-Old Female.
Periasamy K, Radhakrishna N, Mukherji A, Ganesh RN. Periasamy K, et al. Among authors: radhakrishna n. Ochsner J. 2018 Winter;18(4):395-397. doi: 10.31486/toj.17.0107. Ochsner J. 2018. PMID: 30559626 Free PMC article.
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG; Australian Mepolizumab Registry Investigators. Harvey ES, et al. Among authors: radhakrishna n. Respir Med. 2025 Nov;248:108340. doi: 10.1016/j.rmed.2025.108340. Epub 2025 Sep 3. Respir Med. 2025. PMID: 40912662 Free article.
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.
Kritikos V, Harvey ES, Stevens S, Katelaris CH, Langton D, Rimmer J, Farah CS, Gillman A, Hew M, Radhakrishna N, Thomas D, Gibson PG; Australian Mepolizumab Registry Investigators. Kritikos V, et al. Among authors: radhakrishna n. J Allergy Clin Immunol Pract. 2023 Mar;11(3):885-895.e13. doi: 10.1016/j.jaip.2022.12.004. Epub 2022 Dec 23. J Allergy Clin Immunol Pract. 2023. PMID: 36572182
41 results